SCIENTURE HOLDINGS, INC. Repayments of Other Short-term Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Repayments of Other Short-term Debt of $111.72 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherShortTermDebt · last filed 2018-10-26
- SCIENTURE HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2018-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2018-06-30 was $61.73K.
- SCIENTURE HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2018-03-31 was $50.00K.
- SCIENTURE HOLDINGS, INC. repayments of other short-term debt for the quarter ending 2017-09-30 was $0.00.
| Period end | Repayments of Other Short-term Debt 3 month | Repayments of Other Short-term Debt 6 month | Repayments of Other Short-term Debt 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $61.73K derived: sum of 2 quarters · filed 2018-10-26 | $111.72K 10-Q · filed 2018-10-26 |
| 2018-06-30 | $61.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $111.72K 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $50.00K 10-Q · filed 2018-04-27 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $0.00 derived: sum of 2 quarters · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $0.00 10-Q · filed 2018-07-27 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-04-27 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $50.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $50.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |